2seventy bio to Participate in Upcoming Investor Conferences
February 05 2024 - 3:05PM
Business Wire
2seventy bio, Inc. (Nasdaq: TSVT), announced today that members
of the management team will present at the following upcoming
investor conferences:
- Guggenheim Healthcare Talks 6th Annual Biotechnology
Conference, the St. Regis New York, fireside chat on Thursday,
February 8th at 1:30 p.m. ET
- Citi’s 2024 Virtual Oncology Leadership Summit, Thursday,
February 22nd at 3:00 p.m. ET
A live webcast will be available via the Investors and Media
section of 2seventy bio’s website at https://ir.2seventybio.com/. A
replay will be archived on 2seventy bio’s site for 30 days
following the event.
About 2seventy bio
Our name, 2seventy bio, reflects why we do what we do - TIME.
Cancer rips time away, and our goal is to work at the maximum speed
of translating human thought into action – 270 miles per hour – to
give the people we serve more time. We are building the leading
immuno-oncology cell therapy company, focused on discovering and
developing new therapies that truly disrupt the cancer treatment
landscape. With a deep understanding of the human body’s immune
response to tumor cells and how to translate cell therapies into
practice, we’re applying this knowledge to deliver next generation
cellular therapies that focus on a broad range of hematologic
malignancies, including the first FDA-approved CAR T cell therapy
for multiple myeloma, as well as solid tumors. Our research and
development is focused on delivering therapies that are designed
with the goal to “think” smarter and faster than the disease.
Importantly, we remain focused on accomplishing these goals by
staying genuine and authentic to our “why” and keeping our people
and culture top of mind every day.
For more information, visit www.2seventybio.com.
Follow 2seventy bio on social media: X (Twitter) and
LinkedIn.
2seventy bio is a trademark of 2seventy bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240205638676/en/
Investors: Elizabeth Pingpank Hickin, 860-463-0469
Elizabeth.pingpank@2seventybio.com
Media: Jenn Snyder, 617-448-0281
Jenn.snyder@2seventybio.com
2seventy bio (NASDAQ:TSVT)
Historical Stock Chart
From Oct 2024 to Nov 2024
2seventy bio (NASDAQ:TSVT)
Historical Stock Chart
From Nov 2023 to Nov 2024